Citalopram exhibits immune-dependent anti-tumor effects by modulating C5aR1+ TAMs
Fangyuan Dong, Shan Zhang, Kaiyuan Song, Luju Jiang, Li-Peng Hu, Qing Li, Xueli Zhang, Jun Li, Mingxuan Feng, Zhiwei Cai, Hong‐Fei Yao, Rong-Kun Li, Hui Li, Jie Chen, Xiaona Hu, , Shu‐Heng Jiang
This study shows citalopram reduces hepatocellular carcinoma by modulating C5aR1+ tumor-associated macrophages and enhancing CD8+ T cell anti-tumor immunity.
eLife · Feb 9, 2026Peer-reviewedCancer Biology